-
The post is a summary of how things look today and under related reading I have included some past posts that may offer a few more details on how the shift it taking place today. Things are also happening and humming as well in China and you can search and find some recent relative posts here as...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-20-2008
Filed under:
Filed under: Pharma/FDA News, My Commentaries, healthcare, Pharma, clinical trials, R and D, India, Economics, Mayo Clinic, Outsourcing, Employment, China pharma
-
This particular statement really bothers me, is CMS now going to take on the role of “doctor here? “ The Bush administration argued that Medicare officials had the right to decide whether the expense incurred for a given item, not just the item itself, was “reasonable and necessary.” How...
-
The National Cancer Institute has made clinical trial participation a top national priority and yet participant levels are still not perhaps where they could be. Yes, this is a big decision for any patient/physician to make as far as whether or not to enroll, but many trials are offering lifesaving...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-02-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, My Commentaries, Investors, health insurance, Pharma, Cancer, clinical trials, HMO, Pharmaceuticals, R and D, Drug Development, Cancer Institute
-
This actually a pretty good start and I have had my own campaign of sorts going on with getting the FDA up to speed, and they are definitely having to play catch up, as are some other government agencies. In prior posts I had written that some clinical studies were still being written in long hand...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-31-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, My Commentaries, healthcare, Education, Pharma, FDA, Personal Health Records, GSK, Consumer Healthcare, Drug Interactions
-
As the article states, you don’t need marketing for cancer drugs, as the need is unfortunately already there, thus marketing for cancer drugs does not necessarily carry the same sales expense as do other drugs. We have all seen the “tiered plans” on what level drugs are listed with insurance coverage...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-13-2008
Filed under:
Filed under: Medically Related, Insurance, Other Items of Interest, My Commentaries, personalized medicine, Genomics, health insurance, Pharma, Prescriptions, Cancer, R and D, Science 2.0
-
Anyone involved and R and D today can certainly take advantage of a Tablet PC. (I think those new fields reps for the FDA might even like this idea and concept too). Why walk around with an “ open pizza box” notebook, watch the video and see the difference and how tablets work while working, and...
-
In other words, this is called Business Intelligence. Lots of it out there to choose from and one from Microsoft specifically related to hospital management and budgets. Before the demise of Wall Street it wasn’t too long ago that I posted about the All Nighter they pulled to mine and try...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-26-2008
Filed under:
Filed under: Medically Related, Technology, Other Items of Interest, My Commentaries, Pharma, Biotech, Cancer, Business Intelligence, R and D, Wall Street, Pricing
-
One more survey, do we really need to spend this money, I think we have a pretty good idea here that it is not many. My personal opinion here would be to spend the money and enable and educate folks on how this can be done, rather than to see how many can’t, it’s an obvious. If the money...
-
Medical Quack on Reuters. Now this is a sad state of affairs to be the prudent consumer, and yet you are potentially taking money out of your doctor's pocket by doing so when it comes to pay for performance for them, so what's up with this when purchasing $4.00 Generic Drugs. BD...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-18-2008
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, My Commentaries, health insurance, Physicians, Pharma, HMO, Generic Drugs, Pay for Performance, Patients
-
This is something in my conversations with physicians that keeps coming up, so I thought I would write up a post. On this blog I provide links to the $4.00 and other cost saving areas for anyone, insurance or no insurance to find the best cost on generic drugs and these are the heaviest hit links...
-
I spent a little time looking around today and there are many "red stars" on this page, which indicate a safety alert from the FDA. Safety alerts come in all shapes and sizes and a red start does not mean to stop taking medications by any means, just an awareness to help both the clinicians...
-
Yes you heard it right, there's an online advertising spot that will grant access to the game, you can perhaps find it on Forbes and other online publications, and you also get to listen to "Viva Viagra" while you play. So who's next in the Pharma game advertising loop? ...
-
Some things in sales don't change no matter what field you are in and Pharma is no different, sales are made by building relationships, in other words, people do business with people they like, so the peer articles maybe could be just a little off target. I spent over 20 years in outside sales...
-
One more Pharma company joins You Tube Channels, GSK, but this post makes a very good point, no embedding, I agree here, what’s up with Glaxo not allowing one to embed! Also as mentioned, where’s the publicity as Eye on the FDA reports that he’s subscriber number 8! Is big pharma still a...
-
A new book out discussing the drug business in the US, Money Talks. Side Effects which was also written by Bass looks at the day to day life of a pharmaceutical sales representative. Public Health or profit seems to be the theme and what the investigations uncover. Big Pharma is much...